TMC Life Sciences Berhad (KLSE:TMCLIFE)

Market Cap	853.52M +7.7%
Revenue (ttm)	387.22M +20.0%
Net Income	12.59M -3.0%
EPS	0.01 -3.0%
Shares Out	1.74B
PE Ratio	67.80
Forward PE	n/a
Dividend	0.00 (0.39%)
Ex-Dividend Date	Dec 8, 2025

Volume	61,600
Average Volume	185,465
Open	0.4800
Previous Close	0.4800
Day's Range	0.4800 - 0.4900
52-Week Range	0.3650 - 0.5750
Beta	0.40
RSI	43.39
Earnings Date	May 22, 2026

About TMC Life Sciences Berhad

TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; property investment; providing pharmacy services and products; management support services; development, marketing, and management of healthcare programmes; a...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1994
• Country: Malaysia
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: TMCLIFE

Financial Performance

In fiscal year 2025, TMC Life Sciences Berhad's revenue was 345.63 million, a decrease of -0.23% compared to the previous year's 346.42 million. Earnings were 3.61 million, a decrease of -91.13%.